BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37852570)

  • 1. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers.
    Guo X; Sun M; Yang P; Meng X; Liu R
    Eur J Pharmacol; 2023 Dec; 960():176103. PubMed ID: 37852570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on mast cells in the tumor microenvironment: Current knowledge and future directions.
    Shi S; Ye L; Yu X; Jin K; Wu W
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188845. PubMed ID: 36476563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast Cells and Resistance to Immunotherapy in Cancer.
    Ribatti D
    Arch Immunol Ther Exp (Warsz); 2023 Apr; 71(1):11. PubMed ID: 37038035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Landscape of Thyroid Cancers: New Insights.
    Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
    Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells as targets for immunotherapy of solid tumors.
    Oldford SA; Marshall JS
    Mol Immunol; 2015 Jan; 63(1):113-24. PubMed ID: 24698842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.
    Ferrari SM; Fallahi P; Galdiero MR; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Varricchi G; Marone G; Antonelli A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells: A double-edged sword in cancer.
    Derakhshani A; Vahidian F; Alihasanzadeh M; Mokhtarzadeh A; Lotfi Nezhad P; Baradaran B
    Immunol Lett; 2019 May; 209():28-35. PubMed ID: 30905824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.
    Kalkusova K; Smite S; Darras E; Taborska P; Stakheev D; Vannucci L; Bartunkova J; Smrz D
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants.
    Willows S; Kulka M
    Cells; 2020 Dec; 9(12):. PubMed ID: 33352850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
    Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast Cells in the Tumor Microenvironment.
    Aponte-López A; Muñoz-Cruz S
    Adv Exp Med Biol; 2020; 1273():159-173. PubMed ID: 33119881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Mast Cell-Derived Adenosine in Cancer.
    Gorzalczany Y; Sagi-Eisenberg R
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of mast cells in anticancer immunity.
    Dalton DK; Noelle RJ
    Cancer Immunol Immunother; 2012 Sep; 61(9):1511-20. PubMed ID: 22527244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast Cells: A New Frontier for Cancer Immunotherapy.
    Lichterman JN; Reddy SM
    Cells; 2021 May; 10(6):. PubMed ID: 34063789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.
    Lu C; Liu Y; Ali NM; Zhang B; Cui X
    Front Immunol; 2022; 13():1039260. PubMed ID: 36741415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive agents targeting tumor microenvironment.
    Sharma SH; Thulasingam S; Nagarajan S
    Life Sci; 2016 Jan; 145():74-84. PubMed ID: 26679106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
    Jiang T; Chen X; Ren X; Yang JM; Cheng Y
    Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.